Company profile
MPX International Corp.
OTC: MPXOF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONReports USD
#693 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 41
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ growth stability, market scale
Methodology →Revenue TTM
$5.3M
Rev growth YoY (TTM)
+19.1%
Net income (FY)
-$21.1M
Employees
200
as of 2026-08-29
Market cap
$14.4k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$5.7M7.2M CAD2021
Net income-$21.1M-26.6M CAD2021
Operating income-$11.5M-14.6M CAD2021
Total assets$39.8M50.7M CAD2021
Liabilities$21.8M27.8M CAD2021
Equity$13.7M17.5M CAD2021
Revenue trend
FY2018 – FY2021 · USD
FY18
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is MPX International Corp.’s revenue?
MPX International Corp. booked $5.7M in FY2021 revenue, growing 142% year over year — faster than most Healthcare companies we track, at a -369.4% net margin.
Peers · Healthcare
Australis Capital Inc.——Lancer Orthodontics, Inc.——Abeona Therapeutics Inc.69BCarePayment Technologies, Inc.——Tristar Wellness Solutions Inc.——WellQuest Medical & Wellness Corporation——Key facts
CEOW. Scott Boyes
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: MPXOF
Employees200
IPO date2019-03-06
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.